Mucolytic syrup based on carbocysteine.
Indications
Coryfin Mucolitico is a cherry and raspberry flavored syrup, which is used as a fluidifier in acute and chronic respiratory tract conditions.
Dosage
The recommended dose in adults is: 1 tablespoon 3 times a day.
The recommended dose in children from 2 to 5 years: 1 teaspoon (5 ml) 2 times a day.
The recommended dose in children from 5 to 10 years: 1 tablespoon (15 ml) 2 times a day.
Composition
Active ingredient
5 ml of syrup contain 250 mg of carbocisteine.
Excipients
Dibasic sodium phosphate; methyl parahydroxybenzoate; sucrose; fruit flavoring; sodium hydroxide; purified water.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant or are planning to become pregnant, or if you are breastfeeding, ask your doctor for advice before taking Coryfin mucolytic. Although the active ingredient is neither teratogenic nor mutagenic and has not shown negative effects on reproductive function in animals, no data are available on its use in human pregnancy.
Therefore, the use of the medicine is contraindicated during pregnancy.
Since the use of the medicine is contraindicated during pregnancy, the use of the medicine is contraindicated during pregnancy.
There are no data available regarding the passage of carbocisteine into breast milk. The use of the medicine is contraindicated during breastfeeding.
Warnings
Mucolytics can induce bronchial obstruction in children under 2 years of age. In fact, the drainage capacity of bronchial mucus is limited in this age group, due to the physiological characteristics of the airways. They should therefore not be used in children under 2 years of age.
Coryfin Mucolitico contains:
• methyl parahydroxybenzoate: may cause allergic reactions (possibly delayed).
• sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine. This medicine contains 6.3 g per dose (one tablespoon) of sucrose. To be taken into consideration in people with diabetes mellitus.
• sodium: this medicine contains 4.8 mmol (or 110.55 mg) of sodium per dose (one tablespoon). To be taken into consideration in people with reduced kidney function or on a low-sodium diet.
Side effects
Dizziness and digestive phenomena such as gastralgia, nausea, and diarrhea may occur. In these cases, it is necessary to reduce the dosage or discontinue therapy. Furthermore, allergic skin rashes and anaphylactic reactions, fixed erythema, may occur. In such cases, discontinue treatment and consult your doctor to establish appropriate therapy. Bronchial obstruction, with an unknown frequency.
Contraindications
Coryfin Mucolitico should not be administered in case of:
• Hypersensitivity to the active substance or to any of the excipients.
• Active peptic ulcer (i.e., of the digestive tract).
• During pregnancy and breastfeeding.
• In children under 2 years of age.
Format
200 ml.
Product Code:FRCM046229
Richiedi info sul prodotto
